These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 711932)
1. Cinoxacin: pharmacokinetics and the effect of probenecid. Israel KS; Black HR; Nelson RL; Brunson MK; Nash JF; Brier GL; Wolney JD J Clin Pharmacol; 1978 Oct; 18(10):491-9. PubMed ID: 711932 [TBL] [Abstract][Full Text] [Related]
2. Influence of probenecid on serum levels and urinary excretion of cinoxacin. Rodriguez N; Madsen PO; Welling PG Antimicrob Agents Chemother; 1979 Mar; 15(3):465-9. PubMed ID: 464575 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of cinoxacin in patients with renal failure. Szwed JJ; Brannon DE; Sloan RS; Luft FC J Antimicrob Chemother; 1978 Sep; 4(5):451-4. PubMed ID: 690045 [No Abstract] [Full Text] [Related]
4. Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function. Maigaard S; Frimodt-Möller N; Welling PG; Madsen PO Antimicrob Agents Chemother; 1979 Sep; 16(3):411-6. PubMed ID: 507797 [TBL] [Abstract][Full Text] [Related]
5. Effects of probenecid on furosemide kinetics and natriuresis in man. Honari J; Blair AD; Cutler RE Clin Pharmacol Ther; 1977 Oct; 22(4):395-401. PubMed ID: 902452 [TBL] [Abstract][Full Text] [Related]
6. Pharmacology of cinoxacin in humans. Black HR; Israel KS; Wolen RL; Brier GL; Obermeyer BD; Ziege EA; Wolny JD Antimicrob Agents Chemother; 1979 Feb; 15(2):165-70. PubMed ID: 426511 [TBL] [Abstract][Full Text] [Related]
7. Cinoxacin concentrations in plasma, urine and prostatic tissue after oral administration to man. Burt RA; Morgan T; Payne JP; Bonner RM Br J Urol; 1977 Apr; 49(2):147-52. PubMed ID: 858034 [TBL] [Abstract][Full Text] [Related]
8. Cinoxacin in female mongrel dogs: effect of urine pH on urinary drug excretion and correlation of in vitro characteristics of oral dosage forms with bioavailability. Quay JF; Childers RF; Johnson DW; Nash JF; Stucky JF J Pharm Sci; 1979 Feb; 68(2):227-32. PubMed ID: 34019 [No Abstract] [Full Text] [Related]
9. The effect of probenecid on the renal elimination of cimetidine. Gisclon LG; Boyd RA; Williams RL; Giacomini KM Clin Pharmacol Ther; 1989 Apr; 45(4):444-52. PubMed ID: 2702802 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of intravenously administered cefmetazole and cefoxitin and effects of probenecid on cefmetazole elimination. Ko H; Cathcart KS; Griffith DL; Peters GR; Adams WJ Antimicrob Agents Chemother; 1989 Mar; 33(3):356-61. PubMed ID: 2729930 [TBL] [Abstract][Full Text] [Related]
11. Effect of probenecid on the pharmacokinetics of DQ-2556, a new 3-quaternary ammonium cephalosporin antibiotic, in humans. Shiba K; Yoshida M; Shimada J; Saito A; Matsubayashi K; Hashimoto S; Yoshida K; Osada Y; Sakai O Chemotherapy; 1992; 38(6):369-75. PubMed ID: 1288960 [TBL] [Abstract][Full Text] [Related]
12. Effect of probenecid on the pharmacokinetics of ceftizoxime. LeBel M; Paone RP; Lewis GP J Antimicrob Chemother; 1983 Aug; 12(2):147-55. PubMed ID: 6311785 [TBL] [Abstract][Full Text] [Related]
13. Effect of probenecid on the pharmacokinetics of moxalactam. DeSante KA; Israel KS; Brier GL; Wolny JD; Hatcher BL Antimicrob Agents Chemother; 1982 Jan; 21(1):58-61. PubMed ID: 6211135 [TBL] [Abstract][Full Text] [Related]
14. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans. Jaehde U; Sörgel F; Reiter A; Sigl G; Naber KG; Schunack W Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947 [TBL] [Abstract][Full Text] [Related]
15. The effect of the interaction of pyrazinamide and probenecid on urinary uric acid excretion in man. Yü TF; Perel J; Berger L; Roboz J; Israili ZH; Dayton PG Am J Med; 1977 Nov; 63(5):723-8. PubMed ID: 930947 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of cinoxacin in normal volunteers and patients with impaired renal function. Ohkawa M; Sugata T; Sawaki M; Okasho A; Kuroda K; Yamada H J Antimicrob Chemother; 1981 Dec; 8(6):447-51. PubMed ID: 7333988 [No Abstract] [Full Text] [Related]
17. Effect of orally administered probenecid on the pharmacokinetics of cefoxitin. Vlasses PH; Holbrook AM; Schrogie JJ; Rogers JD; Ferguson RK; Abrams WB Antimicrob Agents Chemother; 1980 May; 17(5):847-55. PubMed ID: 7396472 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of renal excretion of AM-715, a new quinolonecarboxylic acid derivative, in rabbits, dogs, and humans. Shimada J; Yamaji T; Ueda Y; Uchida H; Kusajima H; Irikura T Antimicrob Agents Chemother; 1983 Jan; 23(1):1-7. PubMed ID: 6219615 [TBL] [Abstract][Full Text] [Related]
19. Renal excretion and pharmacokinetics of foscarnet in HIV sero-positive patients: effect of probenecid pretreatment. Noormohamed FH; Youle MS; Higgs CJ; Gazzard BG; Lant AF Br J Clin Pharmacol; 1997 Jan; 43(1):112-5. PubMed ID: 9056062 [TBL] [Abstract][Full Text] [Related]
20. Effect of probenecid on the kinetics of a single oral 400mg dose of moxifloxacin in healthy male volunteers. Stass H; Sachse R Clin Pharmacokinet; 2001; 40 Suppl 1():71-6. PubMed ID: 11352445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]